Vial

formerly Vial Health Technology

Hyper Scalable Biotech

Vial was founded in 2020, is headquartered in San Francisco, United States, lists 51–200 employees, and has $101.0M in recorded funding across 5 rounds.

Employees
51–200
Founded
2020
Business Model
B2B
Website
vial.com
Total Funding
$101.0M
Last Round
$67.0M Series BNov 2022
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

Vial develops AI-designed therapeutics and operates automated clinical trials that move drug programs from molecular design into human evaluation. Its integrated system combines AI-driven molecule design, automated wet labs, and high-throughput clinical operations to enable parallel development, faster iteration, and lower operational overhead. The company initially focuses on obesity, oncology, inflammation, and neurological diseases across small-molecule, antibody, and RNA therapeutics.

Summary

Vial is a Life Sciences company based in San Francisco, United States, founded in 2020. It lists 51–200 employees. It has raised $101.0M in total across 5 rounds, most recently a $67.0M Series B round in Nov 2022. Investors include Buckley Ventures, General Catalyst and Andreessen Horowitz.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2022
$67.0M

Sign up to see all 5 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vial on Indexed.vc
<a href="https://indexed.vc/companies/vial"><img src="https://indexed.vc/api/badge/company/vial" alt="Vial on Indexed.vc" width="260" height="76" /></a>